These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1277343)

  • 1. [Gynmastics and the vitamin E in the prophylaxis and therapy of thromboembolic disease in gravidity (author's transl)].
    Kliment V; Ziak F; Zajac J; Kovalcíková J
    Cesk Gynekol; 1976 May; 41(3):176-8. PubMed ID: 1277343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oestrogen therapy in pregnancy threatened by haemorrhage (author's transl)].
    Drác P; Uhlír M; Pospísil J; Pánek M; Jelínek J
    Cesk Gynekol; 1973 Nov; 38(9):652-4. PubMed ID: 4765152
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pregnancy and anticoagulant therapy. Indications and strategies].
    Almange C; Schleich JM; Laurent M
    Arch Mal Coeur Vaiss; 2000 May; 93(5):613-8. PubMed ID: 10858859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annotation. Thromboembolism in pregnancy and its management.
    Letsky E; de Swiet M
    Br J Haematol; 1984 Aug; 57(4):543-52. PubMed ID: 6430334
    [No Abstract]   [Full Text] [Related]  

  • 5. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].
    Boda Z; László P; Rejtö L; Tornai I; Pfliegler G; Rák K
    Orv Hetil; 1996 Jan; 137(4):183-5. PubMed ID: 8721833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thromboembolism during pregnancy and possibilities of its prophylaxis].
    Wille P
    Dtsch Gesundheitsw; 1967 Jul; 22(30):1406-12. PubMed ID: 5601202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of thromboembolic disease in the pregnant woman].
    Bordigoni AJ; Aprosio PB; Busnelli LF; Laudanno OS; Roffo RF; de Bordigoni HE; Aun RJ; Rizzardi JL
    Angiologia; 1988; 40(4):133-5. PubMed ID: 3177942
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboembolic disease in pregnancy: a prospective trial of intermittent heparin therapy during the antepartum period.
    Deiter RW
    J Am Osteopath Assoc; 1985 Apr; 85(4):247-51. PubMed ID: 4044320
    [No Abstract]   [Full Text] [Related]  

  • 9. [The point system in the prevention of thromboembolic diseases in obstetrics].
    Kotál L; Kucera M
    Cesk Gynekol; 1965 Nov; 30(9):674-8. PubMed ID: 5850194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current concepts of venous thromboembolism and anticoagulation during pregnancy].
    Collado Peña S; Villanueva LA
    Ginecol Obstet Mex; 2004 Apr; 72():150-61. PubMed ID: 15318755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of thromboembolic disease by vitamin E.
    Kanofsky JD; Kanofsky PB
    N Engl J Med; 1981 Jul; 305(3):173-4. PubMed ID: 7242594
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant therapy during pregnancy. A new approach.
    Olwin JH; Koppel JL
    Obstet Gynecol; 1969 Dec; 34(6):847-52. PubMed ID: 5366028
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arterial hypertension in gravidity and the authors' experience with Crystepin therapy (author's transl)].
    Baková O; Blekta M; Zivný J
    Cesk Gynekol; 1976 Apr; 41(2):112-3. PubMed ID: 817804
    [No Abstract]   [Full Text] [Related]  

  • 14. ACOG committee opinion. Anticoagulation with low-molecular-weight heparin during pregnancy. Number 211, November 1998. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 1999 Apr; 65(1):89-90. PubMed ID: 10390110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of our prophylaxis of thromboembolism].
    Sahunja P; Wenner R
    Gynaecologia; 1969; 168(1):63-77. PubMed ID: 5816957
    [No Abstract]   [Full Text] [Related]  

  • 16. [Administration of low-molecular-weight heparins in obstetrics].
    Nikolov A; Kovachev I; Petkov Iu; Dimitrov A
    Akush Ginekol (Sofiia); 2000; 40(4):28-33. PubMed ID: 11288629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Latest developments on risk factors and prophylaxis of thromboembolic disease in obstetrics].
    Chauleur C; Gris JC; Seffert P; Mismetti P
    Gynecol Obstet Fertil; 2012 May; 40(5):301-7. PubMed ID: 22516050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-sympathomimetics, causal treatment of EPH-gestosis (author's transl)].
    Rippmann ET
    Schweiz Rundsch Med Prax; 1976 Mar; 65(10):277-82. PubMed ID: 1257186
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of physical therapy in peripheral arterial circulatory diseases (author's transl)].
    Krause D; Dittmar K
    Munch Med Wochenschr; 1973 Oct; 115(40):1742-4. PubMed ID: 4801041
    [No Abstract]   [Full Text] [Related]  

  • 20. Low risk of recurrent thromboembolism in pregnancy.
    de Swiet M; Floyd E; Letsky E
    Br J Hosp Med; 1987 Sep; 38(3):264. PubMed ID: 3676551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.